14. Identltylng alternatlve accountlng treatments: A 10"\": venture was just formed, and one of the venture-rs (companies that invested in the JV) contributed a drug patent with a basis of $10 million but an estimated fair value of $20 million. List two accounting measurement alternatives available for the joint venture to recognize the contributed patent. Explain. (Notably, the Codication does not directly provide guidance for this issue, so your goal during this exercise isjust to brainstorm.)